Afshari Behrooz, Shiri Nasrin, Ghoreishi Fatemeh Sadat, Valianpour Mohtasham
Kashan University of Medical Science, Kashan, Iran.
Islamic Azad University-Kashan Branch, Kashan, Iran.
Depress Res Treat. 2020 Dec 14;2020:2543541. doi: 10.1155/2020/2543541. eCollection 2020.
Schizophrenia (SC), bipolar disorder (BD), and major depressive disorder (MDD) are associated with various cognitive and executive dysfunctions. The aim of the present study was to evaluate and compare cognitive and executive dysfunctions in schizophrenia, bipolar disorder, and major depressive disorder.
Sixty-four schizophrenia patients, 68 bipolar patients, 62 patients with major depressive disorder, and 75 healthy individuals participated in the present study. All participants were assessed with the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Young Mania Rating Scale (YMRS), Positive and Negative Syndrome Scale (PANSS), Beck Depression Inventory (BDI-II), Trial Making Test (TMT), Four-Choice Reaction Time Task, Ruler Drop Method (RDM), Tower of London (TOL) task, and the Wisconsin Card Sorting Task (WCST). Data were analyzed by chi-square, Kolmogorov-Smirnov, and independent -tests; ANOVA; and MANOVA.
In the cognitive function, the scores of SC, BD, and MDD patients were lower than those of healthy individuals. Also, the scores of MDD patients were lower than those of other patients, and the scores of BD patients were lower than those of SC patients. In the executive function, the scores of SC, BD, and MDD patients were lower than those of healthy individuals. Moreover, the scores of the MDD group were higher than those of the BD and SC groups, and the scores of the SC group were higher than those of the BD group.
Patients with SC, BD, and MDD have poorer cognitive and executive functions than healthy individuals, even when these patients are in a stable state. Assessment of cognitive and executive functions in SC, BD, and MDD patients can help in understanding the pathology of these disorders.
精神分裂症(SC)、双相情感障碍(BD)和重度抑郁症(MDD)与各种认知和执行功能障碍相关。本研究的目的是评估和比较精神分裂症、双相情感障碍和重度抑郁症患者的认知和执行功能障碍。
64例精神分裂症患者、68例双相情感障碍患者、62例重度抑郁症患者和75名健康个体参与了本研究。所有参与者均接受了《精神疾病诊断与统计手册》第四版轴I障碍的结构化临床访谈(SCID-I)、杨氏躁狂量表(YMRS)、阳性和阴性症状量表(PANSS)、贝克抑郁量表(BDI-II)、连线测验(TMT)、四选一反应时任务、直尺掉落法(RDM)、伦敦塔(TOL)任务和威斯康星卡片分类任务(WCST)的评估。数据采用卡方检验、柯尔莫哥洛夫-斯米尔诺夫检验和独立样本t检验、方差分析(ANOVA)以及多变量方差分析(MANOVA)进行分析。
在认知功能方面,精神分裂症、双相情感障碍和重度抑郁症患者的得分低于健康个体。此外,重度抑郁症患者的得分低于其他患者,双相情感障碍患者的得分低于精神分裂症患者。在执行功能方面,精神分裂症、双相情感障碍和重度抑郁症患者得分低于健康个体。而且,重度抑郁症组的得分高于双相情感障碍组和精神分裂症组,精神分裂症组的得分高于双相情感障碍组。
精神分裂症、双相情感障碍和重度抑郁症患者的认知和执行功能比健康个体差,即使这些患者处于稳定状态。对精神分裂症、双相情感障碍和重度抑郁症患者的认知和执行功能进行评估有助于了解这些疾病的病理。